Intriguingly, this finding raises the possibility that the molecular basis for disease co-pathology (e.g., findings of synucleinopathy plus tauopathy in the same brain regions) could be due to the early or preferential loss of CTSB or AEP activity.” Here, CTSB is linked to synucleinopathy.